Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.

Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, Suveges D, Vrousgou O, Whetzel PL, Amode R, Guillen JA, Riat HS, Trevanion SJ, Hall P, Junkins H, Flicek P, Burdett T, Hindorff LA, Cunningham F, Parkinson H.

Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012. doi: 10.1093/nar/gky1120.

2.

A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.

Morales J, Welter D, Bowler EH, Cerezo M, Harris LW, McMahon AC, Hall P, Junkins HA, Milano A, Hastings E, Malangone C, Buniello A, Burdett T, Flicek P, Parkinson H, Cunningham F, Hindorff LA, MacArthur JAL.

Genome Biol. 2018 Feb 15;19(1):21. doi: 10.1186/s13059-018-1396-2.

3.

Motivating participation in open science by examining researcher incentives.

Ali-Khan SE, Harris LW, Gold ER.

Elife. 2017 Oct 30;6. pii: e29319. doi: 10.7554/eLife.29319.

4.

Correction: A Complete Fossil-Calibrated Phylogeny of Seed Plant Families as a Tool for Comparative Analyses: Testing the 'Time for Speciation' Hypothesis.

Harris LW, Davies TJ.

PLoS One. 2017 Feb 21;12(2):e0172816. doi: 10.1371/journal.pone.0172816. eCollection 2017.

5.

A Complete Fossil-Calibrated Phylogeny of Seed Plant Families as a Tool for Comparative Analyses: Testing the 'Time for Speciation' Hypothesis.

Harris LW, Davies TJ.

PLoS One. 2016 Oct 5;11(10):e0162907. doi: 10.1371/journal.pone.0162907. eCollection 2016. Erratum in: PLoS One. 2017 Feb 21;12 (2):e0172816.

6.

Smoking and membership in a fraternity or sorority: a systematic review of the literature.

Cheney MK, Harris LW, Gowin MJ, Huber J.

J Am Coll Health. 2014;62(4):264-76. doi: 10.1080/07448481.2014.891595. Review.

PMID:
24527968
7.

Identification of a molecular profile associated with immune status in first-onset schizophrenia patients.

Herberth M, Rahmoune H, Schwarz E, Koethe D, Harris LW, Kranaster L, Witt SH, Spain M, Barnes A, Schmolz M, Leweke MF, Guest PC, Bahn S.

Clin Schizophr Relat Psychoses. 2014 Jan;7(4):207-15. doi: 10.3371/CSRP.HERA.020113.

PMID:
23395839
8.

Comparison of peripheral and central schizophrenia biomarker profiles.

Harris LW, Pietsch S, Cheng TM, Schwarz E, Guest PC, Bahn S.

PLoS One. 2012;7(10):e46368. doi: 10.1371/journal.pone.0046368. Epub 2012 Oct 30.

9.

Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies.

Harris LW, Guest PC, Wayland MT, Umrania Y, Krishnamurthy D, Rahmoune H, Bahn S.

Psychoneuroendocrinology. 2013 Jun;38(6):752-66. doi: 10.1016/j.psyneuen.2012.09.009. Epub 2012 Oct 22. Review.

PMID:
23084727
10.

Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission.

Guest PC, Urday S, Ma D, Stelzhammer V, Harris LW, Amess B, Pietsch S, Oheim C, Ozanne SE, Bahn S.

Proteomics. 2012 Dec;12(23-24):3580-9. doi: 10.1002/pmic.201200376. Epub 2012 Nov 12.

PMID:
23071080
11.

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.

Martins-de-Souza D, Guest PC, Harris LW, Vanattou-Saifoudine N, Webster MJ, Rahmoune H, Bahn S.

Transl Psychiatry. 2012 Mar 13;2:e87. doi: 10.1038/tp.2012.13.

12.

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.

Martins-de-Souza D, Alsaif M, Ernst A, Harris LW, Aerts N, Lenaerts I, Peeters PJ, Amess B, Rahmoune H, Bahn S, Guest PC.

BMC Res Notes. 2012 Mar 15;5:146. doi: 10.1186/1756-0500-5-146.

13.

Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects.

Krishnamurthy D, Harris LW, Levin Y, Koutroukides TA, Rahmoune H, Pietsch S, Vanattou-Saifoudine N, Leweke FM, Guest PC, Bahn S.

World J Biol Psychiatry. 2013 Sep;14(7):478-89. doi: 10.3109/15622975.2011.601759. Epub 2012 Jan 17.

PMID:
22248022
14.

Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.

Guest PC, Martins-de-Souza D, Vanattou-Saifoudine N, Harris LW, Bahn S.

Int Rev Neurobiol. 2011;101:145-68. doi: 10.1016/B978-0-12-387718-5.00006-7. Review.

PMID:
22050851
15.

Proteomic technologies for biomarker studies in psychiatry: advances and needs.

Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Harris LW, Bahn S.

Int Rev Neurobiol. 2011;101:65-94. doi: 10.1016/B978-0-12-387718-5.00004-3. Review.

PMID:
22050849
16.

The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.

Hradetzky E, Sanderson TM, Tsang TM, Sherwood JL, Fitzjohn SM, Lakics V, Malik N, Schoeffmann S, O'Neill MJ, Cheng TM, Harris LW, Rahmoune H, Guest PC, Sher E, Collingridge GL, Holmes E, Tricklebank MD, Bahn S.

Neuropsychopharmacology. 2012 Jan;37(2):364-77. doi: 10.1038/npp.2011.219. Epub 2011 Sep 28.

17.

Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry.

Martins-de-Souza D, Guest PC, Steeb H, Pietsch S, Rahmoune H, Harris LW, Bahn S.

Proteomics. 2011 Jun;11(11):2347-53. doi: 10.1002/pmic.201000718. Epub 2011 May 2.

PMID:
21538886
18.

Identification of a biological signature for schizophrenia in serum.

Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S.

Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.

PMID:
21483431
19.

Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry.

Krishnamurthy D, Levin Y, Harris LW, Umrania Y, Bahn S, Guest PC.

Proteomics. 2011 Feb;11(3):495-500. doi: 10.1002/pmic.201000496. Epub 2011 Jan 11.

PMID:
21268279
20.

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.

Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, van Beveren NJ, Spain M, Barnes A, Steiner J, Rahmoune H, Bahn S.

Psychoneuroendocrinology. 2011 Aug;36(7):1092-6. doi: 10.1016/j.psyneuen.2010.12.018. Epub 2011 Jan 20.

PMID:
21251762
21.

Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.

Chan MK, Tsang TM, Harris LW, Guest PC, Holmes E, Bahn S.

Mol Psychiatry. 2011 Dec;16(12):1189-202. doi: 10.1038/mp.2010.100. Epub 2010 Oct 5.

PMID:
20921955
22.

The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.

Martins-de-Souza D, Harris LW, Guest PC, Bahn S.

Antioxid Redox Signal. 2011 Oct 1;15(7):2067-79. doi: 10.1089/ars.2010.3459. Epub 2010 Dec 2. Review.

PMID:
20673161
23.

Evolution of neuronal and endothelial transcriptomes in primates.

Giger T, Khaitovich P, Somel M, Lorenc A, Lizano E, Harris LW, Ryan MM, Lan M, Wayland MT, Bahn S, Pääbo S.

Genome Biol Evol. 2010 Jul 12;2:284-92. doi: 10.1093/gbe/evq018.

24.

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.

Herberth M, Koethe D, Cheng TM, Krzyszton ND, Schoeffmann S, Guest PC, Rahmoune H, Harris LW, Kranaster L, Leweke FM, Bahn S.

Mol Psychiatry. 2011 Aug;16(8):848-59. doi: 10.1038/mp.2010.71. Epub 2010 Jun 29.

PMID:
20585325
25.

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.

Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren JM, Rothermundt M, McAllister G, Leweke FM, Steiner J, Bahn S.

Mol Psychiatry. 2010 Feb;15(2):118-9. doi: 10.1038/mp.2009.81. No abstract available.

PMID:
20098438
26.

Identification of targeted analyte clusters for studies of schizophrenia.

Cheng TM, Lu YE, Guest PC, Rahmoune H, Harris LW, Wang L, Ma D, Stelzhammer V, Umrania Y, Wayland MT, Lió P, Bahn S.

Mol Cell Proteomics. 2010 Mar;9(3):510-22. doi: 10.1074/mcp.M900372-MCP200. Epub 2009 Dec 10.

27.

The role of proteomics in depression research.

Martins-de-Souza D, Harris LW, Guest PC, Turck CW, Bahn S.

Eur Arch Psychiatry Clin Neurosci. 2010 Sep;260(6):499-506. doi: 10.1007/s00406-009-0093-2. Epub 2009 Dec 9.

28.

Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.

Wang L, Lockstone HE, Guest PC, Levin Y, Palotás A, Pietsch S, Schwarz E, Rahmoune H, Harris LW, Ma D, Bahn S.

J Proteome Res. 2010 Jan;9(1):521-7. doi: 10.1021/pr900867x.

PMID:
19916557
29.

Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia.

Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S.

BMC Med Genomics. 2009 May 20;2:28. doi: 10.1186/1755-8794-2-28.

30.

The cerebral microvasculature in schizophrenia: a laser capture microdissection study.

Harris LW, Wayland M, Lan M, Ryan M, Giger T, Lockstone H, Wuethrich I, Mimmack M, Wang L, Kotter M, Craddock R, Bahn S.

PLoS One. 2008;3(12):e3964. doi: 10.1371/journal.pone.0003964. Epub 2008 Dec 17.

31.

Metabolic changes in schizophrenia and human brain evolution.

Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ, Zhou J, Somel M, Harris LW, Holmes E, Pääbo S, Bahn S.

Genome Biol. 2008;9(8):R124. doi: 10.1186/gb-2008-9-8-r124. Epub 2008 Aug 5.

32.

Genome-wide patterns of gene flow across a house mouse hybrid zone.

Teeter KC, Payseur BA, Harris LW, Bakewell MA, Thibodeau LM, O'Brien JE, Krenz JG, Sans-Fuentes MA, Nachman MW, Tucker PK.

Genome Res. 2008 Jan;18(1):67-76. Epub 2007 Nov 19.

33.

Gene expression profiling in the adult Down syndrome brain.

Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S.

Genomics. 2007 Dec;90(6):647-60. Epub 2007 Oct 22.

34.

Role of morphogens in brain growth.

Tannahill D, Harris LW, Keynes R.

J Neurobiol. 2005 Sep 15;64(4):367-75. Review.

35.

Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector.

van der Weyden L, Adams DJ, Harris LW, Tannahill D, Arends MJ, Bradley A.

Genesis. 2005 Apr;41(4):171-8.

PMID:
15789413
36.

Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome.

Aligianis IA, Johnson CA, Gissen P, Chen D, Hampshire D, Hoffmann K, Maina EN, Morgan NV, Tee L, Morton J, Ainsworth JR, Horn D, Rosser E, Cole TR, Stolte-Dijkstra I, Fieggen K, Clayton-Smith J, Mégarbané A, Shield JP, Newbury-Ecob R, Dobyns WB, Graham JM Jr, Kjaer KW, Warburg M, Bond J, Trembath RC, Harris LW, Takai Y, Mundlos S, Tannahill D, Woods CG, Maher ER.

Nat Genet. 2005 Mar;37(3):221-3.

PMID:
15696165
37.

Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism.

Harris LW, Sharp T, Gartlon J, Jones DN, Harrison PJ.

Eur J Neurosci. 2003 Sep;18(6):1706-10.

PMID:
14511349
38.

Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine.

Anderson DR, Harris LW, Chang FC, Baze WB, Capacio BR, Byers SL, Lennox WJ.

Drug Chem Toxicol. 1997 Aug;20(3):115-31.

PMID:
9292273
39.

Erythrocyte and plasma cholinesterase activity in male and female rhesus monkeys before and after exposure to sarin.

Woodard CL, Calamaio CA, Kaminskis A, Anderson DR, Harris LW, Martin DG.

Fundam Appl Toxicol. 1994 Oct;23(3):342-7.

PMID:
7835534
40.

Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs.

Anderson DR, Gennings C, Carter WH, Harris LW, Lennox WJ, Bowersox SL, Solana RP.

Fundam Appl Toxicol. 1994 May;22(4):588-93.

PMID:
8056205
41.

Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs.

Harris LW, Gennings C, Carter WH, Anderson DR, Lennox WJ, Bowersox SL, Solana RP.

Drug Chem Toxicol. 1994;17(1):35-50.

PMID:
8168432
42.

Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity.

Anderson DR, Harris LW, Bowersox SL, Lennox WJ, Anders JC.

Drug Chem Toxicol. 1994;17(2):139-48.

PMID:
8062641
43.

Endoscopic techniques in neurosurgery.

Harris LW.

Microsurgery. 1994;15(8):541-6. Review.

PMID:
7830535
44.

Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents.

Koplovitz I, Harris LW, Anderson DR, Lennox WJ, Stewart JR.

Fundam Appl Toxicol. 1992 Jan;18(1):102-6.

PMID:
1601200
45.

Acetylcholinesterase inhibition and anti-soman efficacy of homologs of physostigmine.

Harris LW, Anderson DR, Pastelak AM, Bowersox SL, Vanderpool BA, Lennox WJ.

Drug Chem Toxicol. 1992;15(2):127-43.

PMID:
1597127
46.

The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.

Anderson DR, Harris LW, Woodard CL, Lennox WJ.

Drug Chem Toxicol. 1992;15(4):285-94.

PMID:
1459041
47.

Successful pretreatment/therapy of soman, sarin and VX intoxication.

Lennox WJ, Harris LW, Anderson DR, Solana RP, Murrow ML, Wade JV.

Drug Chem Toxicol. 1992;15(4):271-83.

PMID:
1459040
48.

Use of the accelerating rotarod for assessment of motor performance decrement induced by potential anticonvulsant compounds in nerve agent poisoning.

Capacio BR, Harris LW, Anderson DR, Lennox WJ, Gales V, Dawson JS.

Drug Chem Toxicol. 1992;15(3):177-201.

PMID:
1425360
49.

A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.

Ray R, Clark OE 3rd, Ford KW, Knight KR, Harris LW, Broomfield CA.

Fundam Appl Toxicol. 1991 Feb;16(2):267-74.

PMID:
2055358
50.

Evaluation of phosphinates as potential pretreatments for nerve agents.

Anderson DR, Harris LW, Lieske CN, Lennox WJ.

Life Sci. 1991;48(25):2463-8.

PMID:
2046471

Supplemental Content

Loading ...
Support Center